SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-036811
Filing Date
2024-03-27
Accepted
2024-03-27 07:05:13
Documents
13
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aura-20240327.htm   iXBRL 8-K 41960
2 EX-99.1 aura-ex99_1.htm EX-99.1 174963
3 GRAPHIC img28679202_0.jpg GRAPHIC 2706
  Complete submission text file 0000950170-24-036811.txt   351692

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20240327.xsd EX-101.SCH 26008
16 EXTRACTED XBRL INSTANCE DOCUMENT aura-20240327_htm.xml XML 4925
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 24785750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)